Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:In vitro genotoxicity assessment of graphene quantum dots using a 3D HepG2 model : version v1
Authors:ID Durmišević, Irma (Author)
ID Haverić, Anja (Author)
ID Kološa, Katja (Author)
ID Žegura, Bojana (Author)
Files:URL URL - Source URL, visit https://zenodo.org/records/18415123
 
.docx DOCX - Research data, download (26,18 KB)
MD5: D520AC026E3FF358179B70DAE975BEA6
 
.json JSON - Metadata, download (4,59 KB)
MD5: B177FF5617D223969E3C32F9A4B5D067
 
Language:English
Typology:2.20 - Complete scientific database of research data
Organization:Logo NIB - National Institute of Biology
Abstract:Graphene quantum dots (GQDs) are nano-sized fragments of graphene sheets, with great potential for applications in optics, electrochemistry, and biomedicine, including drug delivery. In this study, two types of GQDs were investigated: green-emitting (G-GQD) and blue-emitting (B-GQD) and their genotoxic potential was examined on the protein level. Flow cytometric analysis of γH2AX, a marker of DNA double-strand breaks, and phosphorylated histone H3 (p-H3), a marker of aneugenic activity, was performed in HepG2 spheroids after 24 hours of exposure to G-GQDs and B-GQDs. HepG2 spheroids were exposed to graded concentrations of B- and G-GQD (12.5, 25, 50, and 100 μg/mL) for 24 hours, respectively. Spheroids were dissociated into single-cell suspensions, washed twice with 1x PBS and fixed in 4% PFA. For flow cytometric analysis, cells were labelled with anti-H2AX pS139 antibody and anti-histone H3 pS128 antibody. REA-APC and REA-PE controls were applied to exclude non-specific antibody binding. For each sample, 10,000 events were acquired using a MACSQuant Analyzer 10 flow cytometer and MACSQuantify™ software (Miltenyi Biotech, Germany). Raw data were exported from the MACSQuantify software and analysed with FlowJo V10 software (Becton Dickinson, New Jersey, USA).
Keywords:nanomaterials, graphene quantum dots, HepG2 spheroids, toxicity
Publication status:Published
Publication version:Version of Record
Publication date:29.01.2026
Place of publishing:Genève
Place of performance:Genève
Publisher:Zenodo
Year of publishing:2026
Year of performance:2026
Number of pages:1 spletni vir
PID:20.500.12556/DiRROS-31433 New window
UDC:579
DOI:10.5281/zenodo.18415123 New window
COBISS.SI-ID:280617475 New window
Note:Nasl. z. nasl. zaslona; Opis vira z dne 5. 6. 2026; Soavtorji: Haverić, Anja; Kološa, Katja; Zegura, Bojana;
Publication date in DiRROS:31.07.2026
Views:43
Downloads:31
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Document is financed by a project

Funder:EC - European Commission
Funding programme:HE
Project number:101079113
Name:TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER
Acronym:CutCancer

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:nanodelci, grafenske kvantne pike, in vitro 3D celični model, toksičnost


Collection

This document is a part of these collections:
  1. In vitro toxicity assessment of graphene quantum dots using a 3D HepG2 model

Back